SwedenLivingWorld world_2_fill WorldBusiness BusinessSports sports-soccer SportsEntertainmentEntertain

The UK Approves Alzheimer's Medication

Despite a no in July from the European Medicines Agency EMA, the drug Leqembi is now approved for treatment of Alzheimer's patients in the United Kingdom.

» Updated: 07 September 2024, 08:43

» Published: 24 August 2024

The UK Approves Alzheimer's Medication
Photo: Martina Holmberg/TT

Alzheimer's patients and their relatives had high hopes that the braking medicine Leqembi would be approved in the EU for the treatment of early Alzheimer's disease. But as a cold shower in the middle of the summer, the EMA said no.

Now the medicine is getting permission in the UK, for certain patient groups, writes the company Bioarctic in a press release. For example, it will not apply to patients with a double set of the Alzheimer's risk gene ApoE4, which is about 10-15 percent of patients.

It also seems very unclear whether the medicine will be subsidized by the British healthcare system NHS.

According to the EMA's decision in July, Leqembi indeed affects the underlying causes of Alzheimer's, but the effect was small on patients' symptoms and disease progression. The health benefit is not sufficient in relation to potential drawbacks and side effects, such as swelling and risk of bleeding in the brain, according to the EMA.

With roughly the same reasoning, the British authority Nice assesses that the medicine will not be subsidized.

The medicine has previously been approved in, among other countries, the USA, Japan, and China. The Swedish company Bioarctic, which is behind the discovery that forms the basis for the medicine, has requested a review of the EMA's decision.

Tags
TTT
By TTThis article has been altered and translated by Sweden Herald

More news

Airline Launches Thailand Route from Arlanda
1 MIN READ

Airline Launches Thailand Route from Arlanda

Slight increase in apartment building
1 MIN READ

Slight increase in apartment building

Northvolt's cash would have only lasted a week
2 MIN READ

Northvolt's cash would have only lasted a week

Strike hits French Cognac
1 MIN READ

Strike hits French Cognac

Upbeat in Japan – Gloomy in China
1 MIN READ

Upbeat in Japan – Gloomy in China

Took a tough stance on crypto companies - resigns
1 MIN READ

Took a tough stance on crypto companies - resigns

Ingvar Carlsson on PG: "A very loyal friend"
2 MIN READ

Ingvar Carlsson on PG: "A very loyal friend"

No Wage Guarantee in American Process
1 MIN READ

No Wage Guarantee in American Process

He became "PG" to the entire Swedish people
3 MIN READ

He became "PG" to the entire Swedish people

PG Gyllenhammar has died: "meant a lot"
1 MIN READ

PG Gyllenhammar has died: "meant a lot"

Unstable US stock market ends on a plus
1 MIN READ

Unstable US stock market ends on a plus

Temu's owner shows its hand
1 MIN READ

Temu's owner shows its hand

Nvidia rises in pre-trading on Wall Street
1 MIN READ

Nvidia rises in pre-trading on Wall Street

Reconstruction in the USA to save Northvolt
3 MIN READ

Reconstruction in the USA to save Northvolt

Northvolt: Negotiations are still ongoing
3 MIN READ

Northvolt: Negotiations are still ongoing

Higher Compensation for Job Interviews in Another Location
1 MIN READ

Higher Compensation for Job Interviews in Another Location

Vehicle Giant Warns of Challenges in 2025
1 MIN READ

Vehicle Giant Warns of Challenges in 2025

Unchanged interest rate in Turkey
1 MIN READ

Unchanged interest rate in Turkey

Trump anxiety in the EU over US tariffs
3 MIN READ

Trump anxiety in the EU over US tariffs

Weak demand for scrapping premium
1 MIN READ

Weak demand for scrapping premium